CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference.

CareDx’s management is scheduled to present at the Raymond James & Associates’ 44th Annual Institutional Investors Conference on Monday, March 6th, 2023, at 4:35 PM ET. To listen to the webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  263.57
+5.68 (2.20%)
AAPL  352.90
+0.99 (0.28%)
AMD  506.15
+2.74 (0.54%)
BAC  48.87
-0.57 (-1.16%)
GOOG  279.44
+1.84 (0.66%)
META  612.86
-6.01 (-0.97%)
MSFT  502.22
-4.02 (-0.79%)
NVDA  152.00
-3.46 (-2.23%)
ORCL  114.20
-0.80 (-0.70%)
TSLA  379.99
-0.12 (-0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.